TScan Therapeutics Inc.

NASDAQ: TCRX · Real-Time Price · USD
1.54
-0.06 (-4.05%)
At close: May 01, 2025, 3:59 PM
1.55
0.59%
After-hours: May 01, 2025, 04:20 PM EDT

TScan Therapeutics Revenue

TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending December 31, 2024, TScan Therapeutics generated $665K in revenue.
Revenue (ttm)
$2.82M
Revenue Growth
-86.62%
Price / Sales Ratio
120.9
Revenue / Employee
$14.52K
Employees
194
Market Cap
87.2M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.